| Stem definition | Drug id | CAS RN |
|---|---|---|
| calcium channel blockers, nifedipine derivatives | 4099 | 103129-82-4 |
None
None
None
None
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Blood urea increased | 47.09 | 35.41 | 16 | 509 | 48774 | 79695089 |
| Neutrophil count increased | 46.32 | 35.41 | 14 | 511 | 29382 | 79714481 |
| Lymphocyte count decreased | 43.64 | 35.41 | 15 | 510 | 47274 | 79696589 |
None
| Source | Code | Description |
|---|---|---|
| ATC | C08CA17 | CARDIOVASCULAR SYSTEM CALCIUM CHANNEL BLOCKERS SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS Dihydropyridine derivatives |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.0 | Basic |
| pKa2 | 1.55 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Voltage-gated L-type calcium channel | Ion channel | BLOCKER | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE |
| ID | Source |
|---|---|
| 736178-83-9 | SECONDARY_CAS_RN |
| 150566-71-5 | SECONDARY_CAS_RN |
| D08941 | KEGG_DRUG |
| 4039729 | VANDF |
| C2717539 | UMLSCUI |
| 6UB | PDB_CHEM_ID |
| CHEMBL2111097 | ChEMBL_ID |
| CHEMBL2107350 | ChEMBL_ID |
| DB09237 | DRUGBANK_ID |
| C542574 | MESH_SUPPLEMENTAL_RECORD_UI |
| C000711385 | MESH_SUPPLEMENTAL_RECORD_UI |
| 8835 | INN_ID |
| 0P6NLP6806 | UNII |
| 9822750 | PUBCHEM_CID |
| 2376944 | RXNORM |
| 360548 | MMSL |
| d08466 | MMSL |
| 018248 | NDDF |
| 1217308000 | SNOMEDCT_US |
| 1217324004 | SNOMEDCT_US |
| 1217325003 | SNOMEDCT_US |
None